Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

HC Wainwright & Co. Downgrades Spectrum Pharma to Neutral

Author: Benzinga Newsdesk | April 26, 2023 09:32am
HC Wainwright & Co. analyst Edward White downgrades Spectrum Pharma (NASDAQ:SPPI) from Buy to Neutral.

Posted In: SPPI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist